Holen Sie sich die Stockscreener-App
2.6737
4.85%
-0.1363
Exicure Inc Aktie (XCUR) Neueste Nachrichten
XCUR Q2 2022 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Reports No RevenueHigh Estimate Range - Newser
Exicure (XCUR) Q2 2022 Earnings: Wider-Than-Expected Loss Fails to Deter InvestorsStock Idea Network - Newser
Exicure Inc. (XCUR) Slips 3.6% as Shares Test Support Near $2.53Stock Idea Hub - Newser
XCUR Technical Analysis | Trend, Signals & Chart Patterns | EXICURE INC (NASDAQ:XCUR) - ChartMill
XCUR Q2 2022 Earnings: Wider-than-Expected Loss Highlights Challenges for Pre-Revenue Biotech - Newser
Exicure Inc stock (US30205M1027): micro-cap biotech restructures after Nasdaq delisting - AD HOC NEWS
Exicure delays quarterly filing, trims quarterly loss - TipRanks
Exicure (XCUR) delays Q1 2026 10-Q; prelim net loss $1.83M - Stock Titan
Exicure (XCUR) Declines -10.69% Amid Market Weakness 2026-05-15Descending Triangle - Newser
Exicure stock (US30205M1027): Filing highlights ongoing biotech focus - AD HOC NEWS
TradingKey - TradingKey
XCUR (Exicure) shares decline 3% after EPS miss of 35.6%, raising concerns over biotech's cash burn and growth prospects.Trending Social Stocks - Newser
The biggest catalyst for Exicure (XCUR) nobody is watching (-1.82%) 2026-05-11Open Trading Community - Newser
Number of shareholders of Exicure, Inc. – SWB:2H0 - TradingView
What Exicure (XCUR) does that its rivals cannot (+2.12%) 2026-05-08Investment Community Signals - newser.com
The real value proposition of Exicure (XCUR) stock (-0.29%) 2026-05-06Crowd Risk Alerts - newser.com
XCUR Exicure shares drop 4.67% after Q2 2022 loss per share comes in far wider than analyst estimates.Social Buzz Stocks - Newser
XCUR Exicure Inc. posts wider than projected Q1 2022 loss while its shares climb on positive investor sentiment. - UBND thành phố Hải Phòng
Exicure, Inc. and Adbiotech Co., Ltd. Announce Co-Development Agreement for Burixafor Combination Therapies - Quiver Quantitative
Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100) - The Globe and Mail
Exicure announces co-development agreement with Adbiotech for burixafor (GPC-100) - marketscreener.com
New Exicure pact targets Burixafor combos for sickle cell, leukemia - Stock Titan
Exicure, Inc. And Adbiotech Co., Ltd. Enter Co-Development Agreement For Burixafor (GPC-100) - marketscreener.com
Exicure (XCUR) Stock: Next Week (Touches Low) 2026-04-20Crowd Risk Alerts - Cổng thông tin điện tử tỉnh Lào Cai
Exicure Inc (FRA:2H0) Stock Price, Trades & News - GuruFocus
What do insiders think about Exicure (XCUR) Stock | Price at $3.81, Up 0.87%Alpha Picks - Newser
Exicure, Inc. Appoints Yoontae Han as Director and Young Seung Ko as COO in April 2026 Leadership Update - Minichart
Exicure Strengthens Leadership With New COO and Director - TipRanks
Exicure appoints Yoontae Han to board and Young Seung Ko as COO - TradingView
Exicure (NASDAQ: XCUR) names new COO and appoints board director - Stock Titan
Rate Cut: Can Exicure Inc continue delivering strong returnsQuarterly Earnings Report & Community Verified Swing Trade Signals - baoquankhu1.vn
XCUR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Is Exicure (XCUR) Stock Gaining Momentum | Price at $3.84, Down 4.24%Stock Idea Hub - Newser
XCUR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Price performance - Yahoo Finance Australia
Exicure Reaches Preliminary Settlement in Derivative Lawsuits - The Globe and Mail
Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions - Bitget
Exicure Announces Proposed Settlement of Stockholder Derivative Lawsuits - National Today
Exicure (NASDAQ: XCUR) advances derivative case settlement with new governance controls - Stock Titan
How does Exicure (XCUR) Stock compare to competitors | Price at $4.19, Up 0.24%Social Trade Signals - Newser
Aug Technicals: Does Exicure Inc offer margin of safetyNew Guidance & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
XCUR Should I Buy - Intellectia AI
Bull Run: How does Exicure Inc score in quality rankingsMarket Risk Summary & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Exicure, Inc. (NASDAQ:XCUR) Short Interest Update - Defense World
Analyst Calls: Is Exicure Inc stock heavily shortedWeekly Investment Recap & Daily Price Action Insights - baoquankhu1.vn
Rate Hike: Will Exicure Inc stock go up in YEAR2026 Winners & Losers & Free High Return Stock Watch Alerts - baoquankhu1.vn
Exicure, Inc. Files Form 8-K with SEC – Company Info, Stock Symbol XCUR, and NASDAQ Listing Details - minichart.com.sg
Exicure director Sangjin Yeo resigns from board and audit committee By Investing.com - Investing.com India
Exicure director Sangjin Yeo resigns from board and audit committee - Investing.com
Exicure’s Smart Money Exodus Signals No Near-Term Value in a Vanishing Cash Runway - Bitget
Exicure Announces Routine Board and Audit Committee Change - TipRanks
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):